Literature DB >> 19444618

Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum.

Mukesh C Gohel1, Shital H Bariya.   

Abstract

The objective of present investigation was to develop venlafaxine hydrochloride-layered tablets for obtaining sustained drug release. The tablets containing venlafaxine hydrochloride 150 mg were prepared by wet granulation technique using xanthan gum in the middle layer and barrier layers. The granules and tablets were characterized. The in vitro drug dissolution study was conducted in distilled water. The tablets containing two lower strengths were also developed using the same percentage composition of the middle layer. Kinetics of drug release was studied. The optimized batches were tested for water uptake study. Radar diagrams are provided to compare the performance of formulated tablets with the reference products, Effexor XR capsules. The granules ready for compression exhibited good flow and compressibility when xanthan gum was used in the intragranular and extragranular fractions. Monolayer tablets failed to give the release pattern similar to that of the reference product. The drug release was best explained by Weibull model. A unified Weibull equation was evolved to express drug release from the formulated tablets. Lactose facilitated drug release from barrier layers. Substantial water uptake and gelling of xanthan gum appears to be responsible for sustained drug release. The present study underlines the importance of formulation factors in achieving same drug release pattern from three strengths of venlafaxine hydrochloride tablets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444618      PMCID: PMC2690807          DOI: 10.1208/s12249-009-9244-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  22 in total

1.  Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics.

Authors:  P J Cox; K A Khan; D L Munday; J Sujja-areevath
Journal:  Int J Pharm       Date:  1999-12-20       Impact factor: 5.875

2.  A new in vitro/in vivo kinetic correlation method for nitrofurantoin matrix tablet formulations.

Authors:  G Ertan; H Y Karasulu; E Karasulu; M A Ege; T Köse; T Güneri
Journal:  Drug Dev Ind Pharm       Date:  2000-07       Impact factor: 3.225

3.  Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale.

Authors:  N Billa; K H Yuen
Journal:  AAPS PharmSciTech       Date:  2000-10-08       Impact factor: 3.246

4.  Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function.

Authors:  Aristides Dokoumetzidis; Vasiliki Papadopoulou; Panos Macheras
Journal:  Pharm Res       Date:  2006-01-25       Impact factor: 4.200

5.  An alternative method to the evaluation of similarity factor in dissolution testing.

Authors:  P Costa
Journal:  Int J Pharm       Date:  2001-06-04       Impact factor: 5.875

6.  Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms.

Authors:  D L Munday; P J Cox
Journal:  Int J Pharm       Date:  2000-08-10       Impact factor: 5.875

7.  Guar-based monolithic matrix systems: effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics.

Authors:  Thomas Dürig; Reza Fassihi
Journal:  J Control Release       Date:  2002-04-23       Impact factor: 9.776

8.  Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices.

Authors:  Dipasree Sinha Roy; Bhagwan D Rohera
Journal:  Eur J Pharm Sci       Date:  2002-08       Impact factor: 4.384

9.  Studies in preparation and evaluation of pH-independent sustained-release matrix tablets of verapamil HCl using directly compressible Eudragits.

Authors:  Mukesh C Gohel; Tejas P Patel; Shital H Bariya
Journal:  Pharm Dev Technol       Date:  2003       Impact factor: 3.133

Review 10.  The treatment of depression with different formulations of venlafaxine: a comparative analysis.

Authors:  James S Olver; Graham D Burrows; Trevor R Norman
Journal:  Hum Psychopharmacol       Date:  2004-01       Impact factor: 1.672

View more
  3 in total

1.  Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet.

Authors:  Ahmed A Aboelwafa; Emad B Basalious
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

2.  Preparation and in vitro evaluation of guar gum based triple-layer matrix tablet of diclofenac sodium.

Authors:  H V Chavda; M S Patel; C N Patel
Journal:  Res Pharm Sci       Date:  2012-01

3.  Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride.

Authors:  Munira M Momin; Snehal Kane; Pooja Abhang
Journal:  Front Pharmacol       Date:  2015-07-09       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.